Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Alzheimer's disease (AD) presents significant global health and economic challenges.
• Key pathological features of AD include amyloid-beta (Aβ) deposition, neurofibrillary tangles, and neuroinflammation.
• While Aβ plaques were historically considered the primary driver of neurodegeneration in AD, emerging evidence highlights the critical role of inflammation.

Purpose of the Study:

• To review the role of microglial receptors in Alzheimer's disease pathogenesis.
• To explore how these receptors mediate amyloid-beta (Aβ) recognition, uptake, and signaling.
• To discuss the implications of microglial receptor function in AD.

Main Methods:

• Review of existing scientific literature on Alzheimer's disease, neuroinflammation, and microglial cell biology.
• Analysis of the mechanisms by which amyloid-beta (Aβ) interacts with microglial innate immune receptors.
• Discussion of the dual role of microglia in AD pathogenesis: Aβ clearance and inflammatory mediator release.

Main Results:

• Microglia, the brain's resident macrophages, are central to the inflammatory response in AD.
• Amyloid-beta (Aβ) activates microglia via various innate immune receptors.
• These receptors are implicated in the recognition, internalization, clearance of Aβ, and subsequent microglial activation and signaling.

Conclusions:

• Neuroinflammation, driven by microglial activation, is a critical component of Alzheimer's disease pathogenesis.
• Understanding the specific microglial receptors involved in Aβ recognition and signaling is crucial for developing targeted AD therapies.
• Further research into these receptor-mediated pathways may reveal novel therapeutic strategies for Alzheimer's disease.